Sale!

PDE10A Gene Dyskinesia Limb and Orofacial Infantile-Onset Genetic Test

Original price was: $700.Current price is: $500.

-29%

The PDE10A Gene Dyskinesia Limb and Orofacial Infantile-Onset NGS Genetic DNA Test is a specialized diagnostic tool that identifies mutations in the PDE10A gene responsible for early-onset movement disorders. This comprehensive genetic analysis helps diagnose infants and children experiencing involuntary limb movements and facial dyskinesias. Using next-generation sequencing technology, the test provides precise detection of genetic variants associated with this rare neurological condition. Early diagnosis through this $500 USD test enables timely intervention and appropriate management strategies. The test requires a simple blood sample or extracted DNA and delivers results within 3-4 weeks. Genetic counseling is recommended before testing to understand family history implications.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

PDE10A Gene Dyskinesia Limb and Orofacial Infantile-Onset NGS Genetic DNA Test

Understanding PDE10A Gene Dyskinesia

The PDE10A Gene Dyskinesia Limb and Orofacial Infantile-Onset NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This specialized test focuses on identifying mutations in the phosphodiesterase 10A (PDE10A) gene, which plays a crucial role in regulating cyclic nucleotide signaling in the basal ganglia—the brain region responsible for movement control.

Infantile-onset dyskinesias involving limb movements and orofacial regions are rare neurological conditions that can significantly impact a child’s development and quality of life. Early and accurate diagnosis through genetic testing is essential for implementing appropriate treatment strategies and understanding the long-term prognosis.

What This Test Detects

Our advanced NGS (Next-Generation Sequencing) technology specifically targets:

  • Pathogenic variants in the PDE10A gene associated with movement disorders
  • Point mutations, insertions, and deletions affecting gene function
  • Genetic markers for infantile-onset chorea and dystonia
  • Variants impacting basal ganglia signaling pathways
  • Inheritance patterns for family planning considerations

Who Should Consider This Test

This genetic test is recommended for infants and children presenting with:

  • Involuntary limb movements appearing in infancy
  • Orofacial dyskinesias affecting mouth and facial muscles
  • Choreiform movements (dance-like, irregular motions)
  • Dystonic posturing or muscle contractions
  • Family history of similar movement disorders
  • Unexplained developmental delays with movement abnormalities
  • Suspected genetic movement disorders without clear diagnosis

Key Benefits of PDE10A Genetic Testing

  • Accurate Diagnosis: Provides definitive genetic confirmation of PDE10A-related dyskinesia
  • Early Intervention: Enables timely treatment planning and management strategies
  • Family Planning: Identifies inheritance patterns for future family planning decisions
  • Treatment Guidance: Informs medication choices and therapeutic approaches
  • Prognostic Information: Helps understand disease progression and long-term outcomes
  • Research Contribution: Advances scientific understanding of rare movement disorders

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of board-certified geneticists and neurologists:

Positive Result

A positive result indicates the presence of a pathogenic variant in the PDE10A gene. This confirms the genetic basis of the movement disorder and allows for:

  • Targeted treatment approaches
  • Family member testing recommendations
  • Long-term management planning
  • Connection with support networks

Negative Result

A negative result means no pathogenic variants were detected in the PDE10A gene. This may indicate:

  • Other genetic causes for the movement disorder
  • Need for additional genetic testing
  • Non-genetic factors contributing to symptoms

Variant of Uncertain Significance (VUS)

Sometimes, genetic changes are identified whose clinical significance is unknown. In such cases, we provide:

  • Detailed explanation of the finding
  • Recommendations for family studies
  • Guidance for ongoing monitoring
  • Updates as new research emerges

Test Pricing and Details

Test Feature Details
Test Name PDE10A Gene Dyskinesia Limb and Orofacial Infantile-Onset NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before scheduling your test, we recommend:

  • Complete clinical history documentation
  • Genetic counseling session to discuss implications
  • Family pedigree chart development
  • Discussion of potential outcomes and next steps

Nationwide Testing Availability

We have convenient testing locations across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.

Take the Next Step Toward Diagnosis

If you suspect your child may have PDE10A-related dyskinesia, don’t wait to get answers. Early genetic diagnosis can make a significant difference in treatment outcomes and quality of life. Our team of genetic specialists is ready to guide you through the testing process and provide comprehensive support.

Call us today at +1(267) 388-9828 to schedule your genetic counseling session and book the PDE10A Gene Dyskinesia Test. Take control of your child’s neurological health with definitive genetic answers.